Inherited Bleeding Disorders Flashcards
What is an inherited bleeding disorder?
An acquired defect which effects coagulation of the blood
In what ways can the coagulation cascade be effected by inherited bleeding disorders?
How can platelets be effected?
• a reduction in one, or more, of the coagulation factors or control proteins
- Too little clot formed - haemophilia
- Too much clot formed - thrombophilia
• platelets can be effected in relation to:
- number
- function
List 4 disorders that reduce coagulation factors
- Factor VIII deficiency
- haemophilia/haemophilia A - Factor IX deficiency
- Christmas disease disease/haemophilia B - Von Willebrand’s disease
- reduced factor VIII level
- reduced platelet aggregation - Factor XI deficiency
- common in Askenazy Jew population
What causes haemophilia A and B?
Who is effected?
- A defective gene on the X chromosome
2. Males are affected and females are carriers
State the level of clotting factors (VIII and IX for A and B) present in severe, moderate, mild and carrier cases of haemophilia
- Severe - <2% activity (<0.02 iu/ml)
- Moderate - 2-9% activity (0.02-0.09 iu/ml)
- Mild - 10-40% activity (0.1-0.4 iu/ml)
- Carriers - >50% activity (>0.5 iu/ml)
How are severe and moderate cases of haemophilia A managed?
- Require the use of recombinant factor VIII
How are mild and carrier cases of haemophilia A managed?
- Majority of patients respond to DDAVP (desmopressin)
- this releases factor VIII that has been bound to endothelial cells, giving a temporary boost factor VIII levels and clotting ability - In very mild cases tranexamic acid may be used
- inhibits fibrinolysis (keeps any clot that is formed)
Why is DDAVP only effective with occasional use?
Because there is a finite amount of factor VIII bound to endothelial cell walls and this takes time to re accumulate once it is released
How are severe, moderate, mild and carrier cases of haemophilia B managed and why?
- All require the use of recombinant factor IX
- DDAVP will not work as factor IX is not bound to the cardiovascular wall
- tranexemic acid will help with clotting but by itself is insufficient
What are coagulation factor inhibitors and how do they effect haemophilia treatment?
1.These are antibodies which develop to factor VIII and IX
- The more frequently factors are given, the higher the level of coagulation factor inhibitors
- therefore it is important to plan treatment in order to use as few episodes of factor concentrate as possible
What percentage of patients develop an inhibitor when they first start treatment for haemophilia?
- 35-40%
- however this usually disappears shortly after treatment
What causes von Willebrand’s disease and who does it effect?
- Autosomal dominant - not transmitted by the X chromosome
- caused by deficiency of von Willebrand factor
- caused by reduction in factor VIII levels
- both sexes equally affected
• defective vW factor on platelets interacts badly with factor VIII so poor clot activation by platelets
Describe types 1, 2 and 3 of vW disease
- Type 1 - dominant mild
- Type 2 - dominant mild
- Type 3 - recessive severe
How is vW disease managed?
- In severe and moderate cases:
- DDAVP is enough for most - In mild and carrier cases:
- may only require oral tranexamic acid
What is the incidence of inherited blood disorders in the UK?
- Haemophilia A = 1 in 10,000
- Haemophilia B = 1 in 50,000
- vW disease = 1 in 100-500
- Factor XI deficiency = 1 in 50,000